Sponsor
Bastiaan Driehuys
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Bastiaan Driehuys appears in 11 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
11 shownDownstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe AsthmaNCT07139899 · lead sponsor · 2025-11-17
RECRUITING129 Xenon Imaging in Patients Treated With SotaterceptNCT06351345 · lead sponsor · 2025-10-27
RECRUITINGInhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With HypoxemiaNCT07037836 · lead sponsor · 2025-09-29
RECRUITING129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)NCT06104228 · lead sponsor · 2024-08-12
RECRUITING129Xe MRI CardiopulmonaryNCT06038630 · lead sponsor · 2024-01-12
RECRUITINGPulmonary Hypertension SOLARNCT04778046 · lead sponsor · 2023-11-08
RECRUITINGXenon MRI Pulm HypertensionNCT04991454 · lead sponsor · 2021-09-01
RECRUITINGHyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic SclerosisNCT07821398 · lead sponsor · 2026-11-01
NOT_YET_RECRUITINGXenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)NCT06122922 · lead sponsor · 2024-03-15
WITHDRAWNOxidative Stress in AsthmaNCT04512547 · lead sponsor · 2021-04-01
COMPLETEDEffects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRINCT03324607 · lead sponsor · 2018-04-20
COMPLETEDSponsor roles
lead sponsor11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.